University spin-out company
Appears in 1 story
Developer of the vaccine; planning Phase 2
Vaccines have always chased the virus. You wait for a new strain, then design a shot to match it. A team at the University of Cambridge just tested a vaccine built the other way around: a machine-learning model designed its active ingredient to recognize a whole family of coronaviruses at once, including bat viruses that have never infected a person.
Updated Yesterday
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
